ATF4 and hepatocellular carcinoma: While the role of TAZ in modulating ferroptosis is molecular context- and cell type-dependent, a recent study on hepatocellular carcinoma (HCC) reported its implication in preventing ferroptosis in sorafenib-resistant HCC cells through its binding to ATF4 [52].